Table 1.
Clinical characteristics and hormonal data in women with regular menstruation, women in whom less than 5 years had passed since bilateral salpingo-oophorectomy (BSO), and women in whom 5 years or more had passed since their BSO
Characteristic | No BSO | BSO <5 years | BSO ≥5 years | P-valuea |
---|---|---|---|---|
n | 51 | 27 | 32 | |
Age (years) | 47.0 (45.0–49.0) | 49.0 (46.0–51.0) | 58.5c (54.0–63.3) | <0.001 |
BMI (kg/m2) | 23.5 (21.3–25.0) | 25.2 (23.3–26.0) | 23.4 (20.6–24.7) | 0.107 |
Systolic BP (mmHg) | 128.6±11.1 | 130.9±10.1 | 124.6± 16.0 | |
Diastolic BP (mmHg) | 77.1 ±7.1 | 79.8±2.5 | 73.7±11.3 | |
LH (Liu/ml) | 3.5 (2.3–5.3) | 26.3b (20.4–36.2) | 21.3b (13.8–27.7) | <0.001 |
FSH (Liu/ml) | 5.5 (4.6–7.2) | 79.1b (66.0–105.1) | 86.3b (71.9–104.6) | <0.001 |
Estradiol (pg/mL) | 104.0 (71.0–150.0) | 21.0b (12.5–29.0) | 12.5b (12.5–28.0) | <0.001 |
Smokers (%) | 7.4 | 6.3 | 16.7 |
Notes: Data expressed as median (25%–75%) or average ± standard deviation.
Kruskal–Wallis rank test
P<0.01 versus women with regular menstruation
P<0.01 versus women with regular menstruation and women in whom less than 5 years had passed after BSO.
Abbreviations: BMI, body mass index; BP, blood pressure; LH, luteinizing hormone; FSH, follicle-stimulating hormone.